Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
A team of researchers, led by one of Indian origin, has found that a drug recently approved by the US Food and Drug ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Losing weight can support better heart health, but now doctors are warning of their possible impacts on your heart. Ozempic, ...